Table 3 Small-molecule compounds based on structural designing approach
From: Designing strategies of small-molecule compounds for modulating non-coding RNAs in cancer therapy
Compound | Name | Target | Structure | Cancer type | References |
|---|---|---|---|---|---|
11 | AC1MMYR2 | Pre miR-21, MiR-21 |
| Glioblastomas, breast cancer, colon cancers and gastric cancer, etc. | [87] |
12 | Compound 2 | MiR-17–92 cluster |
| Polycystic kidney disease, Prostate cancer, and breast cancer | [22] |
13 | AC1NOD4Q | LncRNA (HOTAIR) |
| Glioblastoma gastric cancer and breast cancer | [23] |
